NEUROASIS
NeurOasis provides treatment for neurological disorders. They provide treatment services for depressive disorder, Parkinson’s disease-related depression, general anxiety disorder, post-traumatic stress disorder, migraine headache, neuropathic pain and fibromyalgia, hallucination, insomnia and OCD, tinnitus, and eating disorders. They provide inquiries through phone calls and email.
NEUROASIS
Industry:
Health Care Hospital Personal Health Therapeutics
Founded:
2018-01-01
Address:
Tucson, Arizona, United States
Country:
United States
Website Url:
http://www.neuroasistms.com
Total Employee:
1+
Status:
Active
Contact:
+1 520 338 2557
Email Addresses:
[email protected]
Official Site Inspections
http://www.neuroasistms.com Semrush global rank: 5.82 M Semrush visits lastest month: 1.43 K
Unable to get host informations!!!
More informations about "NeurOasis"
PathMaker launches first human trial to test …
Sep 18, 2023 · PathMaker Neurosystems has launched a Phase 1 clinical trial that will test its experimental noninvasive nerve-modulating device in people with amyotrophic lateral sclerosis (ALS).See details»
PathMaker Neurosystems – A radical new approach to the non …
PathMaker Neurosystems is a clinical-stage neuromodulation company founded to commercialize recent advances in the development of non-invasive devices that suppress neuronal …See details»
NeuroSystemics – Together we go further.
NeuroSystemics is a Swiss-based global life-centred (not-for-profit) training organization providing personal and collective embodied & relational healing and developmental experiences for a weller and wiser world.”See details»
NeurOasis - Crunchbase Company Profile & Funding
NeurOasis provides treatment for neurological disorders. They provide treatment services for depressive disorder, Parkinson’s disease-related depression, general anxiety disorder, post …See details»
PathMaker Neurosystems Announces Initiation of First-in-Human …
Sep 14, 2023 · PathMaker Neurosystems is a near-commercial stage neuromodulation company developing breakthrough non-invasive systems for the treatment of people with serious …See details»
PathMaker Neurosystems Announces $2.16 Million Award from …
Jun 5, 2024 · PathMaker Neurosystems is a clinical-stage neuromodulation company developing breakthrough non-invasive systems for the treatment of people with serious neurological …See details»
PathMaker Neurosystems Announces Initiation of First-in-Human …
Sep 14, 2023 · PathMaker Neurosystems is a near-commercial stage neuromodulation company developing breakthrough non-invasive systems for the treatment of people with serious …See details»
Muscular Dystrophy Association Awards Venture …
PathMaker Neurosystems is a near-commercial stage neuromodulation company developing breakthrough non-invasive systems for the treatment of people with serious neurological disorders such as stroke and amyotrophic lateral …See details»
NeurOasis TMS | TMS Therapy Organization | 3575
NeurOasis TMS - TMS Therapy Organization - 3575. 4578 N 1st Ave Suite 100, Tucson, AZ 85718 85718 +1 520-338-2557; http://neuroasistms.com/See details»
$2M grant supports new clinical trial of MyoRegulator for ALS
Jun 10, 2024 · The U.S. Department of Defense (DoD) has awarded more than $2 million to help Pathmaker Neurosystems conduct a second clinical trial of its MyoRegulator — an …See details»
Clinical Trial Alert: Medical Device Feasibility Study for …
Dec 21, 2023 · Researchers at PathMaker Neurosystems Inc. are seeking individuals living with amyotrophic lateral sclerosis (ALS) to participate in a feasibility study to evaluate the safety and tolerability of an investigational …See details»
PathMaker Announces First-In-Human Trial of Neurostimulation …
Sep 22, 2023 · According to a recent announcement, PathMaker Neurosystems has initiated a first-in-human study assessing its noninvasive neuromodulation device MyoRegulator in …See details»
PathMaker secures funding from US DoD for neuromodulation …
Jun 7, 2024 · Neuromodulation company PathMaker Neurosystems has secured $2.16m from the US Department of Defense (DoD) to fund a clinical trial using its MyoRegulator investigational …See details»
MDA Awards $600K to Support Neuromodulator in Slowing ALS
Jan 23, 2023 · The Muscular Dystrophy Association (MDA) has invested $600,000 in PathMaker Neurosystems to help bring a potential noninvasive neuromodulator for amyotrophic lateral …See details»
PathMaker begins testing non-invasive neuromodulation device in …
Sep 15, 2023 · PathMaker Neurosystems has started an early feasibility study investigating its non-invasive neuromodulation device in patients with amyotrophic lateral sclerosis (ALS). The …See details»
NeurOasis | Tucson AZ - Facebook
Safe & effective TMS therapy in a calming, spa-like environment. We treat a number of conditions inc.See details»
PathMaker Neurosystems Announces Completion of Pivotal …
Sep 27, 2021 · PathMaker Neurosystems is a near-commercial stage neuromodulation company developing breakthrough non-invasive systems for the treatment of patients with serious …See details»
PathMaker initiates US multicentre trial evaluating non-invasive …
Mar 12, 2022 · PathMaker Neurosystems has announced initiation of its US multicentre clinical trial to evaluate MyoRegulator for the non-invasive treatment of post-stroke upper-limb spasticity.See details»
Chapter 1 The Organization of the Nervous System
To understand this remarkable organ (and the rest of the nervous system), the myriad cell types that constitute the nervous system must be identified, their interconnections traced, and the physiological role of the resulting circuits …See details»
Functional Neurological Disorder (FND) – A Patient's Guide to FND
FND Hope (www.fndhope.org) is an international patient-run registered charity for patients with functional neurological disorders. It has a large and growing amount of material for patients …See details»